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The cellular mechanisms underlying the generation of @A4 in Alzheimer’s disease and its relationship to the normal metabolism of the amyloid 
protein precursor (APP) are unknown, In this report, we show that expression of the C-terminal 100 residues of APP, with (SPA4CT) or without 
(A4CT) a signal sequence in the N-terminal position, in human neuroblastoma cells results in secretion of a 4 kDapA4-like peptide. In A4CT and 
SPA4CT expressing SYSY cells, jIA4 generation could not be inhibited by the lysosomotropic amines chloroquine and ammonium chloride but 
was inhibited by brefeldin A, monensin and methylamine. The last also selectively inhibits APP secretion in neuroblastoma cells [l]. The Iinding 
that chloroquine and ammonium chloride inhibit /IA4 generation from full length APP but not from A4CT and SPA4CT are consistent with the 
assumption that the two cleavages necessary to generate PA4 operate in two different compartments. Our data suggest the cleavage which generates 
the C-terminus of PA4 takes place in the same compartment (late Golgi or endosomal vesicles) in which the APP-secretase operates. 
APP, A4CT, jIA4; Processing; SYSY, Alzheimer’s disease 
1. INTRODUCTION 
Alzheimer’s disease (AD) is an irreversible neurode- 
generative disorder of the human central nervous sys- 
tem. The neuronal dysfunction is correlated with mas- 
sive deposition of fibrillar aggregates in brain paren- 
chyma and blood vessel walls. The major protein com- 
ponent isolated from these deposits is a small polypep- 
tide of 4-4.5 kDa, called the amyloid /3A4 protein due 
to its relative molecular mass and its partial p-pleated 
sheet structure [2-51. The /?A4 subunit of the parenchy- 
ma1 deposits consists of 42-43 residues and is synthe- 
sized as part of a larger protein precursor (amyloid 
protein precursor, APP). At least eight different splice- 
forms of this amyloid protein precursor are encoded by 
the widely expressed APP gene of chromosome 21 [6- 
10]. Proteolytic processing of these transmembrane pro- 
teins, leading to secretion of the extracellular part (se- 
cretory APP, APPsec) [I 11, occurs within the amyloid 
PA4 sequence [ 12,131. This suggests that the N-terminus 
of the amyloid /?A4 protein is not produced by the 
cleavage which leads to secretory APP’s. 
Recent reports have shown that /?A4-related peptides 
are released by cultured cells and can be detected in 
human cerebraspinal fluid [14--171. These and the find- 
ing that the mutation in the APP gene found in two 
Swedish kindreds with familial AD, where onset of 
symptoms and pathology occur much earlier than in 
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sporadic disease, lead to increased fiA4 generation [ 181, 
provide further support for the hypothesis that genera- 
tion and deposition ofpA contributes both to the onset 
and the progression of the disorder. The mechanism of 
the underlying pathological processes is unknown. 
In order to study the steps in the processing of APP 
which lead to PA4 generation, we have expressed, in 
addition to full length APP695, also the C-terminal 100 
residues of APP, with and without a signal sequence, 
termed by us SPA4CT and A4cT, respectively, in the 
human neuroblastoma cell line SYSY. Since /3A4 release 
from A4CT-type APP fragments which carry the PA4 
sequence at the N-terminus depends only on the pro- 
tease generating the C-terminus, we were able to analyse 
the two cleavages generating the C and N-terminus of 
/?A4 independently from each other. 
2. EXPERIMENTAL PROCEDURES 
2.1. Cloning procedures 
Preparation of piasmid DNA, restriction enzyme digestion, agarose 
gel electrophoresis of DNA, DNA ligation and bacterial transfo~a- 
tion were carried out as described by Sambrook et al. 1191. 
2.2. Plasmid construction 
The eucaryotic expression vector CEPlA4CT was obtained by clon- 
ing the 1 kb SmaIIHindIII fragment of SP65lA4CT 1201 into pCEP4 
(Invitrogen), digested with PvuII/HindIII. The resulting plasmid in- 
cludes methionine codon 596 of APP695 as initiation codon, the am- 
yloid PA4 sequence (codons 5976391640 of APP695) and the entire 
C-terminal domain of APP. For construction of CEPISPA4CT the 
SmaI/HindIII fragment from SP65/SPA4CT [ZO] was cloned into 
pCEP4, digested with PvuIYHindIII. The resulting plasmid CEPl 
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SPA4CT encodes the APP signal sequence and two additional residues 
from APP695 (Leu, Glu) in-frame with the amyloid/IA4 sequence and 
the entire C-terminal domain of the APP. CEP/APP695 was obtained 
by cloning the SmaIIHindIII fragment into pCEP, digested with PvuIIl 
HindIII. 
2.3. Tissue culture and transfection 
The subclone neuroblastoma cell line SH-SYSY was grown in equal 
parts of Minimum Essential Medium (MEM, with Earle’s Salts and 
L-glutamine) and Ham’s F-12 supplemented with nonessential amino 
acids (Eagle’s formulation), penicillin (50 U/ml), streptomycin (40 
&ml) and 10% (v/v) fetal calf serum (FCS) (all Gibco/BRL). For 
stable transfection 5 x 10’ cells were seeded onto 60-mm plates, and 
incubated overnight at 37°C. Cells were about 80% confluent prior to 
transfection. Cells were then washed three times with Opti-MEM I 
(GIBCO) prior to addition of the DNA/Lipofectin mixture. The 
DNA/Lipofectin mixture was produced by combining the DNA solu- 
tion (10-20 pug DNA in 1.5 ml Opti-MEM) with the Lipofectin solu- 
tion (3&50 pg Lipofectin (BRL, Eggenstein, Germany) in 1.5 ml 
Opti-MEM). After incubation for 8 h at 37°C cells were grown for 
a further 24 to 48 h in cell-culture medium and stable lines were 
selected by exposure to hygromycin B (300 &ml). 
2.4. Metabolic labelling of tissue culture cells and preparation of cell 
lysates 
After removal of the culture medium, the cells were pretreated with 
2 ml of MEM (for 6 cm cell culture dishes) lacking methionine for 40 
min. Cells were labelled by incubation in 1.5 ml MEM lacking methi- 
none, supplemented with 300 @i of [?S]methionine for 2-3 h. The 
medium was then harvested, and the cells were washed once with 
MEM and scraped from the surface of the dish. For lysis, the cells were 
resuspended in 0.6 ml of SOL (50 mM Tris-HCl, pH 7.5, 150 mM 
NaCl, 2 mM EDTA, 1% Triton X-100) supplemented with 2 mM 
penylmethylsulfonyl fluoride (PMSF) and placed on ice. After 20 min, 
samples were centrifuged at 10,000 x g for 5 min, and the supematants 
(cell lysates) were stored at -20°C for subsequent analysis. 
2.5. Drug treatment 
Ammonium chloride (10 mM), chloroquine (20 PM), brefeldin A 
(10 &ml), monensin (10 PM) and methylamine (30 mM) were added 
to the methionine free medium 30 min prior addition of [?S]methion- 
ine. 
2.6. Pulse-chase labelling of tissue culture cells 
After removal of the culture medium, the cells were treated with 1.5 
ml of MEM lacking methionine for 40 min. Then 500 &i of 
[“Slmethionine were added, and cells were labelled for 20 min at 37°C. 
Cells were then washed once with MEM (37°C) and chased in 
methionine-enriched medium (MEM, 0.3 mg/ml L-methionine, 37°C) 
for the times indicated in results. After the chase period, the cells were 
washed twice with PBS before preperation of cell lysates as described. 
2.7. Immunoprecipitation [21] 
For immunoprecipitation the conditioned medium was first ad- 
justed to 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 2 mM EDTA, 1% 
Triton X-100 and 2 mM PMSF and then medium and cell lysate were 
incubated for 30 min with 5 ,ul pre-immune serum and 30 ~1 (3 mg) 
protein A-Sepharose (Pharmacia). The samples were centrifuged 
briefly and the supematants were incubated with antiserum (5 ~1 anti 
A4CT or 10 ~1 anti 2-43) for 60 min at room temperature. Following 
the incubation, 30 ~1 (3 mg) protein A-Sepharose was added for an 
additional 60 min at room temperature. The insoluble complexes were 
washed three times with wash A (10 mM Tris-HCl, pH 7.5, 150 mM 
NaCI, 0.2% Triton X-100, 2 mM EDTA), two times with wash B (10 
mM Tris-HCI, pH 7.5, 500 mM NaCl, 0.2% Triton X-100, 2 mM 
EDTA) and once with wash C (10 mM Tris-HCl, pH 7.5) before 
pellets were resuspended in 2 x Laemmli sample buffer. After boiling 
for 5 min at lOO”C, labelled proteins were analyzed by SDS-PAGE 
and fluorography with ENrHANCE (Du Pont). 
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3. RESULTS 
3.1. Expression of A4CT and SPA4CT in SY5 Y cells 
Stable expression of the C-terminal 100 residues of 
APP as a cytoplasmic protein (A4CT) or as a transmem- 
brane protein (SPA4CT) was achieved by using the epi- 
somal replication of pCEP4 vectors (Invitrogen). Stable 
cell lines expressing SPA4CT and A4CT, were metabol- 
ically labelled with [35S]methionine, and the im- 
munoprecipitates of cell lysates and conditioned me- 
dium obtained with anti A4CT or an antibody raised 
against synthetic /?A4 peptide 2-43 (anti 2-43) were sub- 
sequently separated on Tris-tricine gels. 
Cell lysates from SYSY cells expressing SPA4CT and 
A4CT revealed additional protein bands at 12 kDa (Fig. 
1, lane 2) and 11.5 kDa (Fig. 1, lane 3) respectively, 
which were not present in the control (Fig. 1, lane 1). 
The bands at higher molecular weights present also in 
untransfected SYSY cells correspond to endogenously- 
expressed APP and fragments thereof. Although the 
signal peptide of SPA4CT was probably cleaved off 
[19], the A4CT-band at 11 S kDa migrated slightly 
below the SPA4CT-band at 12 kDa. This difference in 
molecular mass on SDS-PAGE is due to the two addi- 
tional amino acids present in mature SPA4CT, which 
were introduced together with the signal peptide se- 
quence (see Section 2.2). 
The band at about 10 kDa visible in both untrans- 
cell lysate medium 
123 
A4CT 
CT 
OA4 
Fig. 1. Expression of A4CT and SPA4CT in SYSY cells. Cells were 
transfected with the corresponding constructs, metabolically labelled 
with [?S]methionine, and the immunoprecipitates of cell lysates and 
media were analysed by 16% Tris-Wine-PAGE and fluorography. 
Lanes 1 to 3: cell-lysates; antibody anti A4CT. Lanes 4 to 6: condi- 
tioned medium; antibody: anti 2-43: Lane 1 and 4, nontransfected 
SY5Y cells; lane 2 and 5, SYSY cells transfected with CEP/SPA4CT 
and lane 3 and 6, cells transfected with CEP/A4CT. CT, C-terminal 
membrane associated APP-fragment after APP-secretase cleavage. 
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fected and transfected SYSY cells (Fig. 1 lanes l-3, CT) 
corresponds to the C-terminal fragment of the en- 
dogenously expressed APP, generated by cleavage by 
APP secretase within the PA4 sequence. 
Analysis of conditioned medium from transfected 
cells with anti A4CT did not reveal SPA4CT or A4CT 
signals (data not shown). Identical results were obtained 
with transient transfected COS-cells, HeLa cells and 
PC12 cells (data not shown). 
Analysis of conditioned medium from the transfected 
cells with anti 2-43 revealed aBAClike peptide at 4 kDa 
(Fig. 1, lanes 5 and 6), which was not detectable in 
untransfected SYSY cells under the conditions used 
(Fig. 1, lane 4). The PA4 peptide derived from cells 
expressing SPA4CT migrated slightly above the /?A4 
peptide secreted from A4CT transfected cells. This is 
due to the two additional amino acids present in mature 
SPA4CT (see above) and demonstrates the precursor- 
endproduct relationship between the 4 kDa band and 
SPA4CT and A4CT, respectively. The j?A4-like pep- 
tides could not be detected in cell lysates. 
3.2. Time course of /?A4 generation in SY.5Y cells 
To investigate the biogenesis pathway of A4CT and 
SPA4CT and its metabolism leading to BA4-like pep- 
tides, a pulse-chase labelling experiment was performed. 
The transfected SYSY cells were labelled for 20 min 
with [35S]methionine and chased in complete, methion- 
ine-enriched medium for O-240 min. Immunoprecipi- 
tates of cell lysates at 0 min (zero time) revealed the 12 
kDa band of SPA4CT and the 11.5 kDa band of A4CT 
described above (Fig. 2). In this cellular system A4CT 
had a half-life time of less than 20 min. In contrast, 
SPA4CT seemed to be more stable and showed a half- 
life time of about 40 min. The different half-life times 
call lysates 
SPA4CT A4CT 
I 0 20 40 60 12d 0 20 40 60 ml 
OA4 
of SPA4CT and A4CT could reflect different degrada- 
tion pathways of these APP fragments. 
Analysis of conditioned medium from the transfected 
cells with anti 2-43 revealed the presence of pA4-like 
peptides after 20 min. Thus both, the transmembrane 
protein SPA4CT and A4CT, which lacks the signal pep- 
tide, were processed to BAClike peptides with similar 
time courses. Densiometric measuring of SPA4CT and 
/?A4 signals in Fig. 2 showed that about 60% of the 
precursor SPA4CT was transformed into /3A4. 
3.3. C~mpartmenta~i~ati~n of the APP- and A4CT-proc- 
essing 
To identify the compartment in which PA4 is gener- 
ated, A4CT- and SPA4CT-transfected cells were labeled 
in the presence of compounds which interfere with dis- 
tinct processing pathways. Imunoprecipitation of con- 
ditioned medium of the stable cell lines with anti 2-43 
revealed that for both APP fragments /?A4 generation 
was inhibited by monensin and brefeldin A, but not by 
the lysosomal protease inhibitiors chloroquine and am- 
monium chloride (Fig. 3). Interestingly, PA4 generation 
from SPA4CT could be in~bited by methylamine, an- 
other acidotrophic amine (Fig. 4, medium, lane ‘Me’). 
The generation of /?A4 from full length APP695 was 
partially inhibited by ammonium chloride and fully in- 
hibited by methylamine and brefeldin A (Fig. 4) which 
is in agreement with other publications [21]. 
That the different inhibitors are functionally active 
under the conditions used is shown in Fig. 4. Cell lysates 
from transfected SYSY cells incubated with the differ- 
ent compounds used in Fig. 3 and Fig. 4, were analysed 
by immunoprecipitation with anti A4CT. Ammonium 
chloride and methylamine strongly stabilized the C-ter- 
minal APP-fragment (CT) generated by APP-secretase 
medium 
SPA4CT MCT 
0 20 40 60 12010 20 40 60 124 
Fig. 2. Half-life time of SPA4CT and A4CT’. SYSY cells transfected with CEP/A4CT and CEPBPA4CT were labelled for 20 min with [35S]methion- 
ine and chased in methionine-enriched medium for the times indicated. The proteins were analysed by 16% Tris-tricine-PAGE after immunopre- 
cipitation. Cell lysates: analysis of cell-lysates; antibody anti A4CT. Medium: analysis of conditioned medium; antibody anti 2-43. CT, C-terminal 
membrane associated APP-fragment after APP-secretase cleavage. 
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r C Am MO Br Chlf ~2 1 C Am MO Brl % 
” 
i3A4 
Fig. 3. Compa~~enta~uation of j?A4 generation. SY5Y cells trans- 
fected with CEPIA4CT and CEPISPA4CT were labelled with 
[“Slmethionine for 2 h in the presence or absence of the compounds 
indicated. The conditioned medium was analysed by immunoprecipta- 
tion with anti 2-43 and subsequent Tris-tricine PAGE (16%). Co, 
control; Am, 10 mM ammonium chloride; MO, 10 PM monensin; Br, 
10 ,ug/ml brefeldin A; Chl, 20 ,uM choloroquine; @A4, l-42 translated 
in the wheat germ translation system. 
and normally degraded in the lysosomal compartment 
(Fig. 4, cell lysate). Brefeldin A prevented the genera- 
tion of CT because it blocked APP translocation from 
the golgi stack to the plasma-membrane. 
4. DISCUSSION 
In this study we expressed the C-terminal 100 residues 
of APP with and without a signal sequence at N-termi- 
nal position, termed by us SPA4CT and A4CT, respec- 
tively, in SYSY cells. Expression of SPA4CT should 
allow membrane insertion of A4CT [20] and thus mimic 
the natural situation of this C-terminal fragment of 
APP. It is important to note that both APP-fragments 
start with the /?A4 sequence at the N-terminus and need 
only to be cleaved at the C-terminus of PA4 for its 
release. By using these stable cell lines, in combination 
with full length APP expressing cell lines, it became 
possible to separate functionally the two cleavages nec- 
essary to generate PA4 from full length APP. 
Expression of SPA4CT and A4CT in SYSY cells re- 
sulted in a 12 and 11.5 kDa protein associated with the 
cell lysate. The same results were also obtained with 
HeLa-, COS- and PC-12 cells, transfected with the same 
APP fragments. Both molecules howed no tendency to 
aggregate and are not secreted into the medium. This 
would be expected for cytoplasmic or transmembrane 
proteins but is in contrast to the findings of Wolf et al. 
[23] who suggested that A4CT expressed in CV-1 cells 
aggregates and forms deposits, and to those of Yankner 
et al. [24] who suggested that A4CT is secreted into the 
medium and aggregates there. 
Analysis of cell lysates and conditioned medium of 
the stable cell lines with anti 2-43 showed that both 
A4CT and SPA4CT are processed into lf3A4-like pep- 
tides which are i~ediately secreted into the medium. 
We could not detect any intracellular /IA4 in the cell 
lysates of the transfected cells. The pulse-chase xperi- 
ments showed that the processing of these APP-frag- 
ments into /IA4 is very fast and efficient, because 60% 
of SPA4CT is transformed into /?A4 in less than 20 min. 
In this context it is important to mention that SPA4CT 
seems to be not a good ligand for APP secretase because 
under the conditions used p3, a peptide generated from 
A4CT by cleavage of APP secretase [14], could not be 
detected. Thus our stable transfected cells are a good 
cellular model for studying~A4 generation and the con- 
sequence of the release of the amyloidogenic peptide. 
The inhibition of PA4 generation by acidotrophic 
amines in APP695transfected cells but not in A4CT- 
and SPA4CTQransfected cells suggests that the prote- 
olytic cleavage generating the N-terminus of /?A4, but 
not the C-terminal cleavage, occurs in an acidic com- 
partment. Thus we have been able to separate the cleav- 
age which generates the C-terminus from that for the 
N-terminus of @A4. The C-terminal cleavage is not af- 
fected by ammonium chloride and chloroquine, 
whereas that necessary to generate the N-terminus of 
/IA4 is affected by the lysosotrophic amines. 
This is in contrast to the findings of Shoji et al. [16], 
who showed an inhibition of /3A4 generation from 
SPA4CT by chloroquine and ammonium chloride. 
However, they used concentrations up to 5 times higher 
cell lvsate 
695 SPA4CT 
1 C Am Me Br 1 C Me f 
A4CT 
CT 
medium 
695 SPA4CT 
1 C Am Me Bri G Mel 
l3A4 
Fig. 4. Compartimentaliization f the /?A4 generation. SYSY cells 
transfected with CEP/695 and CEPISPA4CT were labelled and analy 
sed as in Fig. 3. Top: cell-lysates; antibody anti MCT. Bottom: con- 
ditioned medium; antibody: anti 2-43: C, control; Am, 10 mM ammo- 
nium chloride; Me, 30 mM methylamine; Br, 10 @ml brefeldin A; 
Chl, 20pM choloroquine; CT, C-terminal membrane associated APP- 
fragment after APP-secretase cleavage. 
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than used in the current experiments and in this context 
it is important to mention, that at high concentration 
( 2 100 PM), chloroquine has been shown to inhibit 
endocytosis and to be cytotoxic [25]. In our cellular 
model the concentrations used (chloroquine 20 PM and 
ammonium chroride 10 mM) are slightly below the con- 
centrations which inhibit the general incorporation of 
radioactivity, indicating that the biosynthetic activity of 
the cells is not compromised. 
Inhibition of /?A4 production from APP695, 
SPA4CT and A4CT elicited by monensin, which is 
known to inhibit late Golgi and lysosomal function, and 
by brefeldin A, which causes a redistribution of Golgi 
into ER without affecting ER or early Golgi function, 
exclude the possiblity that the proteolytic processing 
which generates the C-terminus and the N-terminus of 
PA4 takes place within the ER or early Golgi. 
Our results also resolve the paradox that A4CT, a 
protein without a signal sequence, leads to a processing 
product (/3A4) released into the medium. The inhibitory 
effects of monensin and brefeldin A on /?A4 generation 
from A4CT suggests that the transmembrane domain 
of A4CT could function as an internal signal peptide 
and lead to insertion into ER. This is in agreement with 
the finding that A4CT and SPA4CT also sediment with 
the cell membrane if expressed in SYSY cells (data not 
shown) or with microsomal membranes if expressed in 
a reticulocyte translation system [20]. 
Because it has been shown that PA4 generation from 
SPA4CT is like secretion of APP [l] only inhibited by 
methylamine but not by the other acidotrophic agents, 
chloroquine and ammonium chloride, we postulate that 
the process generating the C-terminus of PA4 occurs in 
the same or related compartment or maybe elicited by 
the same mechanism as APP secretion. This proposal is 
supported by the finding that PA4 was never detected 
intracellularly. Thus it seems very likely that the cleav- 
age generating the C-terminus of /3A4 occurs at or near 
the plasma membrane in competition with APP-secre- 
tase, and that the /?A4 generated is immediately lost 
from the membrane to the extracellular compartment. 
This suggests that the corresponding compartment car- 
ries several distinct proteases releasing APPsec and 
/3A4, or that APPsecretase and the protease generating 
the C-terminus of /?A4 vA4aseC) are identical. Finally, 
the inhibition of the C-terminal cleavage by methylam- 
ine but not by the other acidotrophic amines may sug- 
gest the involvement in APP processing of transglutam- 
inases, which are specifically inhibited by methylamine. 
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